Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo
Srinivasa Reddy Bonam(Indian Institute of Chemical Biology), Sylviane Muller(Centre National de la Recherche Scientifique)
Cited by 44
Related Papers
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
|Science Translational Medicine|2022|129
A multivalent mRNA-LNP vaccine protects against <i>Clostridioides difficile</i> infection
|Science|2024|73
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases
|Journal of Autoimmunity|2022|23